Pharmafile Logo
Pharmafocus logo
Advanced Search

Boehringer Ingelheim

Showing 11 posts of 116 posts found.

Boehringer Andreas Barner

Boehringer bets on Pradaxa to fill portfolio gaps

April 6, 2011
Research and Development, Sales and Marketing Boehringer, Boehringer Ingelheim, Pradaxa

Boehringer Ingelheim has identified Pradaxa as one of the cornerstones of its “new growth phase” as the manufacturer seeks to …

News
Japanese rescue workers

Japan’s pharma industry pledges to maintain medicines supply

March 17, 2011
Sales and Marketing Astellas, Boehringer Ingelheim, Daiichi Sankyo, Eisai, Japan, earthquake

Pharmaceutical firms in Japan have escaped the very worst of the devastation caused by the earthquake and tsunami, and have …

News
Biberach

Pharmaceutical manufacturing news in brief

February 15, 2011
Manufacturing and Production Boehringer Ingelheim, DSM Biologics, Elan, Novasep

Irish drugmaker Elan has forged an alliance with Boehringer Ingelheim to develop and manufacture antibody-based therapeutics. Under the terms of …

News
ABPI Code of Practice

Boehringer’s Pradaxa advertising breaches Code

January 21, 2011
Medical Communications ABPI, Bayer Schering Pharma, Boehringer Ingelheim, Code of Practice, PMCPA, Sanofi-Aventis

Boehringer Ingelheim has fallen foul of the ABPI Code of Practice on five counts in a row over an advertisement …

News

Amgen plant will boost Boehringer Ingelheim’s US presence

January 21, 2011
Manufacturing and Production Abgenix, Amgen, Boehringer Ingelheim, Vectibix, panitumumab, pharma manufacturing

Germany’s Boehringer Ingelheim has agreed to buy a development and manufacturing facility in Fremont, California, from leading biotechnology firm Amgen. …

News
Blog footer

Digital Pharma: NHS thrombosis e-learning

January 14, 2011
Medical Communications Bayer, Boehringer Ingelheim, Digital Pharma blog, NHS training, Pfizer, Sanofi-Aventis, VTE, e-learning, venous thromboembolism

The NHS has launched a best-practice website to help educate healthcare professionals about one of the most common causes of …

News

Lilly and Boehringer sign major diabetes collaboration

January 12, 2011
Research and Development BI10773, Boehringer Ingelheim, Eli Lilly, LY2605541, LY2963016, TGF-beta monoclonal antibody, diabetes, lilly, linagliptin, type II diabetes

Eli Lilly and Boehringer Ingelheim have signed a multi-million dollar collaboration that will see them develop and commercialise a mid- …

News

Boehringer puts afatinib head-to-head with Herceptin

December 10, 2010
Research and Development BIBW 2992, Boehringer Ingelheim, Herceptin, Roche, Tovok, afatinib, breast cancer

Boehringer Ingelheim has set up a showdown between one of its pipeline oncology products and Roche’s Herceptin. It has started …

News
Blog footer

Digital Pharma: Pfizer and Boehringer’s online COPD awareness

November 12, 2010
Medical Communications Boehringer Ingelheim, COPD, Digital Pharma blog, Managing COPD, NICE, Pfizer, Spiriva, chronic obstructive pulmonary disease

Pfizer and Boehringer Ingelheim have launched an online campaign to publicise the latest NICE guidelines on COPD to healthcare professionals …

News
Pfizer and Boehringer's COPD campaign website

Pfizer and Boehringer pilot COPD campaign

November 9, 2010
Medical Communications Boehringer Ingelheim, COPD, Pfizer, Salford, chronic bronchitis, chronic obstructive pulmonary disease, emphysema

Pfizer and Boehringer Ingelheim have mobilised a soap opera star, painted rugby players and a special ‘breathing bus’ for a …

News

Groundbreaking pharma-NHS collaboration launched in Nottingham

May 30, 2008
ABPI, ABPI Outreach Programme, AstraZeneca, Boehringer Ingelheim, COPD, GlaxoSmithKline, INFORCE, Nottingham, Nycomed, Pfizer, joint working

A group of pharmaceutical companies have joined forces with Nottingham healthcare services to help improve care for patients with chronic …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026